Latest filing published 29 Sept 2026 for Aterian, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by David Natan span 8 companies, the busiest being Titan Pharmaceuticals Inc, FiEE, Inc. and Sunshine Biopharma, Inc. The record holds 12 filings, for trades running from 25 April 2022 to 25 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 29 September 2026, reports a share grant in Aterian, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations